Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
核桃发布了新的文献求助10
2秒前
lcj发布了新的文献求助10
3秒前
3秒前
3秒前
人机发布了新的文献求助10
4秒前
4秒前
文世明完成签到,获得积分10
4秒前
科目三应助baishuo采纳,获得10
4秒前
6秒前
6秒前
CodeCraft应助轻松的凡英采纳,获得10
6秒前
6秒前
2052669099发布了新的文献求助50
6秒前
卑微小哲完成签到,获得积分10
7秒前
汉堡包应助edtaa采纳,获得10
7秒前
桐桐应助以水为师采纳,获得10
9秒前
文世明发布了新的文献求助10
9秒前
molihuakai应助LSY采纳,获得10
10秒前
Lucas应助vfi采纳,获得10
10秒前
呼呼大睡完成签到,获得积分10
11秒前
今后应助科研通管家采纳,获得10
11秒前
大意的如南完成签到,获得积分20
11秒前
思源应助科研通管家采纳,获得10
11秒前
ding应助科研通管家采纳,获得60
11秒前
11秒前
ding应助科研通管家采纳,获得10
11秒前
11秒前
ding应助科研通管家采纳,获得30
11秒前
隐形曼青应助科研通管家采纳,获得10
11秒前
今后应助科研通管家采纳,获得10
12秒前
12秒前
完美世界应助科研通管家采纳,获得10
12秒前
Li梨发布了新的文献求助10
12秒前
小蘑菇应助科研通管家采纳,获得10
12秒前
12秒前
12秒前
科研通AI2S应助科研通管家采纳,获得10
12秒前
华仔应助科研通管家采纳,获得10
12秒前
13秒前
秀丽的大门完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6527340
求助须知:如何正确求助?哪些是违规求助? 8320450
关于积分的说明 17810535
捐赠科研通 5629128
什么是DOI,文献DOI怎么找? 2930169
邀请新用户注册赠送积分活动 1906879
关于科研通互助平台的介绍 1766450